Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease

EuroIntervention 2017;13:1157-1165 published online July 2017. DOI: 10.4244/EIJ-D-17-00328

Mohammad Abdelghani
Mohammad Abdelghani1, MD, MSc; Rafael Cavalcante2, MD, PhD; Yosuke Miyazaki2, MD, PhD; Robbert J. de Winter1, MD, PhD; Jan G. Tijssen1, PhD; Rogério Sarmento-Leite3, MD, PhD; José A. Mangione4, MD, PhD; Alexandre Abizaid5,6, MD, PhD; Pedro A. Lemos7, MD, PhD; Patrick W. Serruys8*, MD, PhD; Fabio S. de Brito Jr6, MD, PhD
1. Department of Cardiology, Academic Medical Center, Amsterdam, the Netherlands; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 3. Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia and Universidade

Aims: In addition to patients with pure/predominant aortic stenosis (PAS), real-world transcatheter aortic valve implantation (TAVI) referrals include patients with mixed aortic valve dis

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic regurgitationaortic stenosisparavalvular leaktranscatheter aortic valve implantation (tavi)
Read next article
Transcatheter edge-to-edge repair of lead-associated tricuspid regurgitation

Latest news